Opening soonN/AAges 18 Years and up
Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis
Sponsor: King Hussein Cancer Center · NCT07553260 on ClinicalTrials.gov ↗
Conditions studied
Acute Radiation DermatitisHead and Neck Cancer (H&N)Sarcomas
What it tests
- Normal Saline Soaks (0.9% Sodium Chloride)other
Where it's running1 site
1 international site
King Hussien Cancer Center
Amman, Al-Jubeiha, Jordan 11941
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Age ≥ 18 years * Eastern Cooperative Oncology Group (ECOG) performance status 0-1 * Patients receiving definitive radiotherapy for sarcomas or head and neck cancer (primary or postoperative treatment) * Planned radiation dose between 60-70 Gy according to disease-specific protocols * No prior history of malignancy other than sarcomas * Ability and willingness to comply with study procedures (\>90% expected adherence) * Signed informed consent Exclusion Criteria: * Patients receiving palliative radiotherapy * Known pre-existing skin disorders affecting radiation area (e.g., systemic lupus erythematosus, scleroderma) * ECOG performance status ≥2 * Previous radiotherapy to the same treatment field * Any condition that, in the investigator's judgment, may interfere with participation or wound healing assessment
Updated 2026-04-27 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.